Ignite Creation Date:
2025-12-24 @ 9:54 PM
Ignite Modification Date:
2026-06-04 @ 5:56 PM
Study NCT ID:
NCT01537432
Status:
COMPLETED
Last Update Posted:
2016-01-05
First Post:
2012-02-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Psoriasis, Plaque-type Psoriasis | View |